Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs

Wen‐Ming Chen; Peng Zhan; De Clercq Erik; Christophe Pannecouque; Jan Balzarini; Xin Jiang; Xinyong Liu

doi:10.1016/j.bmc.2013.09.009

Related publications

Article2022

Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluation

Da Feng, Hao Lin, Liyang Jiang, Jiaojiao Dai, Xiaoying Zhang, Zhongxia Zhou, Yanying Sun, Zhao Wang, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2013

Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs

Dongyue Li, Peng Zhan, Huiqing Liu, Christophe Pannecouque, Jan Balzarini, De Clercq Erik, Xinyong Liu

Article2021

Boronic acid-containing diarylpyrimidine derivatives as novel HIV-1 NNRTIs: Design, synthesis and biological evaluation

Da Feng, Fenju Wei, Yanying Sun, Prem P. Sharma, Tao Zhang, Hao Lin, Brijesh Rathi, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2013

Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs

Diwakar Rai, Wen‐Ming Chen, Ye Tian, Xuwang Chen, Peng Zhan, De Clercq Erik, Christophe Pannecouque, Jan Balzarini, Xinyong Liu

Article1997

New 1,1,3-trioxo-2H,4H-thieno[3,4-e]thiadiazine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase

Myriam Witvrouw, Ma Esther Arranz, Christophe Pannecouque, Ruben Declercq, Heidi Jonckheere, J.C.C. Schmit, Anne‐Mieke Vandamme, Juan H. Ayala, Jan Desmyter, Robert Esnouf, Luc Van Meervelt, Jan Balzarini, Sonia Vega, De Clercq Erik